Hoth Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Hoth Therapeutics Stock Summary

Hoth Therapeutics competes with Avenue Therapeutics, Revelation Biosciences, Virax Biolabs, Zura Bio, and Phio Pharmaceuticals. Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Hoth Therapeutics Key Financial Ratios

Hoth Therapeutics Key Balance Sheet Accounts

Hoth Therapeutics Key Cash Accounts

Hoth Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hoth Therapeutics's current stock value. Our valuation model uses many indicators to compare Hoth Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hoth Therapeutics competition to find correlations between indicators driving Hoth Therapeutics's intrinsic value. More Info.Hoth Therapeutics is rated # 3 in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Hoth Therapeutics' Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hoth Therapeutics' earnings, one of the primary drivers of an investment's value.

Hoth Therapeutics Systematic Risk

Today, most investors in Hoth Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hoth Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Hoth Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Hoth Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hoth Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hoth Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Hoth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hoth Therapeutics's daily price indicators and compare them against related drivers.

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.